ADIŞEN, E. Et Al. 2017. Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents. DERMATOLOGIC THERAPY , vol.30, no.2 .

ADIŞEN, E., Ozer, I., Temel, B., & Gurer, M. A., (2017). Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents. DERMATOLOGIC THERAPY , vol.30, no.2.

ADIŞEN, ESRA Et Al. "Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents," DERMATOLOGIC THERAPY , vol.30, no.2, 2017

ADIŞEN, ESRA Et Al. "Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents." DERMATOLOGIC THERAPY , vol.30, no.2, 2017

ADIŞEN, E. Et Al. (2017) . "Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents." DERMATOLOGIC THERAPY , vol.30, no.2.

@article{article, author={ESRA ADIŞEN Et Al. }, title={Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents}, journal={DERMATOLOGIC THERAPY}, year=2017}